Maxivision Super Speciality Eye Hospitals announced the launch of the revolutionary SMILE 500 technology, aiming to set a new standard in refractive surgery in Vijayawada.
Read More
Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) hosted the second Annual Palliative & Hospice Care Educational Symposium (PACES 2024) at Gulmohar Club, Delhi, bringing together cancer survivors, patients, and healthcare experts to highlight the crucial role of palliative care in cancer treatment.
Read More
In a significant move, India has become an affiliate member of the International Medical Device Regulators Forum (IMDRF), a global group focused on harmonising medical device regulations, the Union Health Ministry announced on Thursday.
Read More_20241003152839_original_image_11.webp)
In a medical achievement, CK Birla Hospital, Delhi successfully performed India’s low-weight bilateral hip replacement surgery on a 65-year-old woman weighing just 23 kg.
Read More
The Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) has announced plans to expand its operations across the National Capital Region (NCR) to provide quality cancer treatment to more people.
Read More (1)_20241001112422_original_image_34.webp)
It is with deep sadness that we announce the passing of Dr Sandip Chatterjee, one of India’s most esteemed neurosurgeons, and a remarkable human being
Read More
Mumbai-based ENTOD Pharmaceuticals is working with the Drug Controller General of India (DCGI) to address concerns over its recently approved Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25per cent w/v, branded as PresVu eye drops. Approved on August 6 for the treatment of presbyopia in adults, the drug's approval was suspended by DCGI on September 10 after healthcare professionals raised concerns.
Read More
The report examined 99,492 samples from public and private healthcare facilities across the country. These samples, collected from areas such as the blood, urine, and respiratory tract, were tested against bacteria like E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus.
Read More
According to the GLOBOCAN 2022 data, lung cancer is the fourth leading cause of cancer-related mortality in India. NSCLC accounts for a significant proportion of these cases, with about 15 per cent of patients having resectable disease, this data underscores the importance of targeted treatment options.
Read More_20240924135536_original_image_25.webp)
The Department of Health Research (DHR), under the Union Health Ministry, has successfully rolled out its ambitious 100 Days Program, marking significant strides in healthcare innovation, pandemic readiness, and the promotion of indigenous medical technologies.
Read More
